首页> 外文期刊>Chromatographia >Simultaneous determination of artesunate and amodiaquine in fixed-dose combination by a RP-HPLC method with double UV detection: Implementation in interlaboratory study involving seven African National Quality Control Laboratories
【24h】

Simultaneous determination of artesunate and amodiaquine in fixed-dose combination by a RP-HPLC method with double UV detection: Implementation in interlaboratory study involving seven African National Quality Control Laboratories

机译:采用双紫外检测的RP-HPLC方法同时测定固定剂量组合中的青蒿琥酯和阿莫地喹:在涉及七个非洲国家质量控制实验室的实验室间研究中实施

获取原文
获取原文并翻译 | 示例
           

摘要

The fixed-dose combination artesunate (AS)-amodiaquine (AQ) is one of the most widely used treatments for uncomplicated falciparum malaria. It is currently proposed to the inclusion in the model list of essential medicines of World Health Organization and has been recently prequalified. Until now, no satisfactory method for the simultaneous determination of the two active ingredients had been available. Thus, a reversed phase high performance liquid chromatography for the quantitative determination of AQ and AS was developed and validated. Chromatography was performed using an end-capped octadecylsilyl silica gel column (100 × 4.6 mm, 3 μm) with a binary gradient using aqueous phase containing potassium dihydrogen phosphate (10 mM) and acetonitrile. Taking into consideration the physico-chemical characteristics of the two compounds related to their ionization, the use of a counter ion was necessary to ensure the retention of AQ in a reversed phase system simultaneously to AS. Thus, aqueous mobile phase was adjusted to pH 3.0 and the chosen counter ion was sodium 1-octanesulfonate (100 mM). In these conditions, the retention times were about 4 min for AQ and 10 min for AS with UV detection at 300 and 210 nm, respectively. Method was then validated according to ICH guideline (specificity/linearity/accuracy/precision) and potential interferences with excipients and degradation products were checked. It has also been used for an interlaboratory study involving seven African National Quality Control Laboratories and Afssaps (Agence fran?aise de sécurité sanitaire des produits de santé) laboratory. The results demonstrate that this rapid and simple method can be easily used by official laboratories for routine control, market survey and for the detection of potential substandard medicines which are very frequent in African countries.
机译:固定剂量联合使用的青蒿琥酯(AS)-阿莫地喹(AQ)是最简单的恶性疟疾治疗方法之一。目前已提议将其列入世界卫生组织基本药物标准清单,并且最近已经进行了资格预审。迄今为止,还没有令人满意的方法可以同时测定两种活性成分。因此,开发并验证了用于定量测定AQ和AS的反相高效液相色谱仪。色谱法使用封端的十八烷基甲硅烷基硅胶色谱柱(100×4.6 mm,3μm),使用含有磷酸二氢钾(10 mM)和乙腈的水相进行二元梯度洗脱。考虑到这两种化合物的电离相关的理化特性,必须使用抗衡离子来确保AQ与AS同时保留在反相系统中。因此,将水相的流动相调节至pH 3.0,选择的抗衡离子为1-辛烷磺酸钠(100 mM)。在这些条件下,AQ的保留时间分别为约4分钟和AS的保留时间分别为300和210 nm的UV检测时间为10分钟。然后根据ICH指南(特异性/线性/准确性/精密度)对方法进行验证,并检查对赋形剂和降解产物的潜在干扰。它也已用于涉及7个非洲国家质量控制实验室和Afssaps(法新社法国安全生产实验室)实验室的实验室间研究。结果表明,这种快速,简单的方法可以被官方实验室轻松地用于常规控制,市场调查以及检测在非洲国家非常常见的潜在不合格药品。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号